Alvotech Lauds Development, Manufacturing Platform As Ustekinumab Wins US Approval

Commercial Partner Teva Eyes Launch In February 2025 For Rival To $7bn Blockbuster

 
• By Dean Rudge
  
FDA approved
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin